// company-profile

Relmada Therapeutics, Inc.

RLMD
ExchangeNasdaqSectorPharmaceutical PreparationsInc.NVFilings54Insiders9
// api This Relmada Therapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

No insider transactions in the last 30 days.

No insider activity recorded for RLMD in the last 90 days.

Institutional Ownership

Top 13F-HR holders of Relmada Therapeutics, Inc. as of 2026-03-31

↑ increasing
Total reported AUM
$575.5M
QoQ change
+141.8%
Reporting period
2026-03-31
#1
JANUS HENDERSON GROUP PLC
CIK 1274173
$76.9M
11.1M shares
#2
Squadron Capital Management LLC
CIK 2050709
$59.0M
8.5M shares
#3
Spruce Street Capital LP
CIK 2050194
$43.0M
6.3M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Dec 15, 2025TRAVERSA SERGIORLMD
Purchase
27,500$4.12$113K
Dec 15, 2025Shenouda MagedRLMD
Purchase
11,665$4.12$48K
Dec 12, 2025Ence ChuckRLMD
Award
828,000$0.00$0K
Dec 12, 2025CASAMENTO CHARLES JRLMD
Award
164,000$0.00$0K
Dec 12, 2025TRAVERSA SERGIORLMD
Award
1,198,000$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.